MultiPlan Newsroom

Piper Sandler Maintains MultiPlan(MPLN.US) With Hold Rating, Cuts Target Price to $10

Futu NewsNov 6 20:31

MultiPlan (MPLN) Receives a Hold From Piper Sandler

TipRanksNov 6 20:30

Piper Sandler Maintains MultiPlan(MPLN.US) With Hold Rating, Maintains Target Price $40

Futu NewsOct 18 19:31

Piper Sandler Sticks to Their Hold Rating for MultiPlan (MPLN)

TipRanksOct 18 18:42

Citi Maintains MultiPlan(MPLN.US) With Hold Rating, Cuts Target Price to $10

Futu NewsSep 24 20:31

MultiPlan Analyst Ratings

BenzingaSep 24 06:04

Citigroup Maintains Neutral on MultiPlan, Lowers Price Target to $10

BenzingaSep 24 06:03

MultiPlan Price Target Cut to $1.00/Share From $2.00 by Piper Sandler

Dow JonesAug 7 20:51

MultiPlan Analyst Ratings

BenzingaAug 7 20:42

Analysts Conflicted on These Healthcare Names: Nyxoah (NYXH), MultiPlan (MPLN) and Beam Therapeutics (BEAM)

TipRanksAug 7 19:08

MultiPlan Analyst Ratings

BenzingaJun 26 18:06

Barclays Sticks to Its Hold Rating for MultiPlan (MPLN)

TipRanksMar 1, 2023 16:21

Barclays Adjusts Price Target on MultiPlan to $1 From $3, Maintains Equal-Weight Rating

MT NewswiresJan 19, 2023 09:55

Goldman Sachs Adjusts Price Target on MultiPlan to $2.05 From $5.50, Maintains Neutral Rating

MT NewswiresNov 16, 2022 23:11